Successful treatment with cyclosporine of pure red cell aplasia induced by obinutuzumab bendamustine therapy-Reference-Cited by-同舟云学术

Successful treatment with cyclosporine of pure red cell aplasia induced by obinutuzumab bendamustine therapy

Published:2023-04-27 Issue:8 Volume:102 Page:2291-2292
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Shimazu Yutaka,Mizumoto Chisaki^ORCID,Chonabayashi Kazuhisa,Hanyu Yuta,Kanda Junya,Takaori-Kondo Akifumi

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-023-05215-4.pdf

Reference12 articles.

1. Brice P, Bastion Y, Lepage E et al (1997) Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d’Etude des Lymphomes Folliculaires. J Clin Oncol 15:1110–1117. https://doi.org/10.1200/JCO.1997.15.3.1110

2. Ardeshna KM, Smith P, Norton A et al (2003) Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. Lancet 362:516–522. https://doi.org/10.1016/S0140-6736(03)14110-4

3. Narra K, Borghaei H, Al-Saleem T et al (2006) Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature. Leuk Res 30:109–114. https://doi.org/10.1016/j.leukres.2005.05.017

4. Diehl LF, Ketchum LH (1998) Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Semin Oncol 25:80–97

5. Sharma VR, Fleming DR, Slone SP (2000) Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab. Blood 96:1184–1186. https://doi.org/10.1182/blood.v96.3.1184.015k54_1184_1186

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diamond-Blackfan anemia with very late and fatal onset aplasia in a 55-year-old patient with RPL11 mutation;Annals of Hematology;2023-11-23

2. Multiple drugs;Reactions Weekly;2023-08-12